Today's Top 20 Gastroenterology and Endoscopy Stories
-
Hepatitis C can be eliminated, study says — 3 insights
A study published in The Lancet claims hepatitis C can be eliminated worldwide by 2030, but several improvements will have to be made to get there, Medscape reports. - 2/4/19 -
Drs. Jeffrey Gordon, Joseph Hancock & more: 8 GI physicians making headlines
Here are eight gastroenterologists featured in the news recently: - 2/1/19 -
GI leader to know: Dr. William Sandborn of UC San Diego Health
William Sandborn, MD, is the gastroenterology division chief at University of California San Diego Health. - 2/1/19 -
Takeda's GI drug continues to be growth-driver for company — 8 insights
Takeda's ulcerative colitis drug Entyvio was one of the key products behind a 10.5 percent increase in underlying revenue for the third quarter of fiscal year 2018. - 2/1/19 -
AGA recognizes 10 GIs, researchers for achievements & contributions to the field
The American Gastroenterological Association announced its annual recognitions, bestowing honors on 10 gastroenterologists and researchers for their contributions to the field. - 2/1/19 -
Video, audio colonoscopy recordings improve quality over audio documentation — 3 study insights
A study published in JAMA Surgery examined the effectiveness of video and audio colonoscopy recordings compared to narrated recording alone, the Oncology Learning Network reports. - 2/1/19 -
12 GI leaders to know | January 2019
Here are 12 GI leaders featured by Becker's ASC Review in January: - 1/31/19 -
5 must-read articles for GI physicians this week: Jan. 24-31
Here are the five most-read gastroenterology articles for the week of Jan. 24-31: - 1/31/19 -
GI probiotic product inventor wins $18M in false advertising suit — 3 insights
A federal jury awarded Claudio De Simone, MD, $18 million after they ruled VSL Pharmaceuticals created an unauthorized copycat product and tried to sell it without clinically testing it. - 1/31/19 -
GI researcher Dr. Jeffrey Gordon wins award for gut microbiome research
Jeffrey Gordon, MD, a gut microbiome researcher and trained gastroenterologist, won the BBVA Foundation Frontiers of Knowledge Award in biology and biomedicine. - 1/30/19 -
GI leader to know: Dr. John Inadomi of UW Medicine
John M. Inadomi, MD, is the gastroenterology division head at the Seattle-based UW Medicine Department of Medicine. - 1/30/19 -
AbbVie, Colorectal Cancer Alliance & more: 3 GI company key notes
Here are three updates on gastroenterology and industry-relevant companies to note: - 1/30/19 -
Barton Health adds Dr. Joseph Hancock — 3 insights
Gastroenterologist Joseph Hancock, MD, joined South Lake Tahoe, Calif.-based Barton Health, SouthTahoeNow.com reports. - 1/30/19 -
Venture capital group invests in Objective GI — 4 insights
TKS 1 made an investment in gastrointestinal-focused clinical research company Objective GI. - 1/30/19 -
Dr. David Boss participating in 'mini-medical school' for local students — 4 insights
Gastroenterologist David Boss, MD, and other physicians are partaking in the Lakewood, N.J.-based Georgian Court University in the mini-medical school speaker series, TheSandPaper.net reports. - 1/30/19 -
ACG endorses Interdisciplinary Autoimmune Summit — 3 insights
The American College of Gastroenterology endorsed HMP's upcoming Interdisciplinary Autoimmune Summit, April 5-7 in Chicago. - 1/29/19 -
4 GIs stump to close the colonoscopy loophole — 3 insights
Four Houston-based Baylor College of Medicine gastroenterologists met with a representative of Sen. John Cornyn, R-Texas, to advocate for National Institutes of Health funding, Patient's Voice Act restoration and to close the colonoscopy loophole. - 1/29/19 -
GI leader to know: Dr. John Thompson of The Children's Hospital of Montefiore
John F. Thompson, MD, is the gastroenterology, hepatology and nutrition division chief at New York City-based The Children's Hospital at Montefiore. - 1/28/19 -
Dr. John Dowd joins Concord Gastroenterology Associates — 3 insights
Concord (N.H.) Gastroenterology Associates added John Dowd, DO, to its staff, MetroWest Daily News reports. - 1/28/19 -
AbbVie posts $8.3B in Q4 earnings, misses analysts' predictions — 5 insights
AbbVie announced its fourth quarter and full year financial results, posting $8.3 billion in quarterly net revenues, up 7.3 percent year over year. - 1/28/19